ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 658,71
1,22%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Praxis Precision Medicines Inc (PRAX)

  7. Praxis Precision Medicines Inc (PRAX) Actualités

PRAX Praxis Precision Medicines Inc

54,54
0,38 (0,70%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Praxis Precision Medicines Inc PRAX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,38 0,70% 54,54 23:30:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
55,40 54,345 55,435 54,54 54,16
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
12/4/202414:00GLOBEPraxis Precision Medicines to Present on Ulixacaltamide at..
05/3/202415:08EDGAR2Form S-3 - Registration statement under Securities Act of..
05/3/202413:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202413:13EDGAR2Form 8-K - Current report
05/3/202413:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202402:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202416:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202401:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202422:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
17/1/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202423:23EDGAR2Form 8-K - Current report
12/1/202423:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/1/202412:01EDGAR2Form 8-K - Current report
10/1/202423:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/1/202422:19GLOBEPraxis Precision Medicines, Inc. Announces Proposed Public..
10/1/202422:10EDGAR2Form 8-K - Current report
10/1/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202403:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202403:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202403:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202323:23EDGAR2Form 8-K - Current report
07/12/202323:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/12/202322:33EDGAR2Form 8-K - Current report
28/11/202313:00GLOBEPraxis Precision Medicines to Showcase Largest Pipeline of..
21/11/202322:00GLOBEPraxis Precision Medicines to Present at the Piper Sandler..
16/11/202314:00GLOBEPraxis Precision Medicines Receives PRIME Designation from..
07/11/202313:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:35EDGAR2Form 8-K - Current report
07/11/202313:00GLOBEPraxis Precision Medicines Provides Corporate Update and..
06/11/202322:24EDGAR2Form 8-K - Current report
02/11/202313:00GLOBEPraxis Precision Medicines to Present at Truist Securities..
16/10/202313:09EDGAR2Form DEF 14A - Other definitive proxy statements
10/10/202313:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202313:56EDGAR2Form PRE 14A - Other preliminary proxy statements
02/10/202319:27EDGAR2Form 8-K - Current report
02/10/202319:17GLOBEPraxis Precision Medicines Provides Portfolio Update at 2023..
27/9/202322:15GLOBEPraxis Precision Medicines To Host Hybrid R&D Day on Monday,..
19/9/202316:25APSBiotech Catches Major Premarket Bid
07/9/202314:00GLOBEPraxis Precision Medicines to Present at H.C. Wainwright..
31/8/202314:00GLOBEPraxis Precision Medicines to Present Data from Epilepsy..
09/8/202314:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202314:27EDGAR2Form 8-K - Current report
09/8/202313:00GLOBEPraxis Precision Medicines Provides Corporate Update and..
08/8/202313:00GLOBEPraxis Precision Medicines Announces Positive Data from..
07/8/202313:00GLOBEPraxis Precision Medicines Announces Positive Results of EEG..

Dernières Valeurs Consultées

NASDAQ
PRAX
Praxis Precision Medicines
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés